Towards better CRS care by better understanding the mechanism of novel therapeutic approaches that modulate the mucosal epithelial barrier
Microbe-mucin isoform crosstalks mediating mucosal barrier function in the gastrointestinal tract versus vagina.
Evaluating the impact of advanced age and age-related diseases on gastrointestinal drug behaviour and on the biochemical barrier of the intestinal mucosa
Skin, mucosal and blood-brain barrier kinetics of model cyclic depsipeptides : the mycotoxins beauvericin and enniatins
The damaged mucosal barrier in intestinal inflammation: interaction with therapeutic bacteria and roles for metallothioneins as immunomodulators
Chitin glucan shifts luminal and mucosal microbial communities, improve epithelial barrier and modulates cytokine production in vitro
Mucosal and blood-brain barrier transport kinetics of the plant N-alkylamide spilanthol using in vitro and in vivo models